BTKwt

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameBTKwt
Drug Alias NameBTK-wt
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase BTK inhibitors
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesX-Rx Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesX-Rx Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A